A patient speaking to a doctor

 

As a company that’s been on the frontlines of drug distribution for nearly two centuries, McKesson is focused on being part of the solution when it comes to building more resilient supply chains that can help mitigate shortages, despite shocks to supply or demand. With deep expertise in pharmaceutical distribution, supply chain analytics, and market access dynamics, we are committed to helping address the multitude of issues contributing to drug shortages. Shortages are not a new concept and can occur because of many different factors. For example, shortages could be caused by higher treatment rates over time (demand), manufacturing and quality challenges, or generic economic deflation, resulting in fewer competitive suppliers within a specific market.

Solving supply chain disruptions requires cooperation and collaboration across all stakeholders — including distributors, manufacturers, payors, pharmacies, providers and government partners. While each drug shortage is unique, together, we can build supply chain resiliency by understanding the root causes and deploying targeted solutions.

Learn more ways we’re fortifying our supply chain and helping our customers continue to receive the medications they need.

 

 

 
Resources on Combatting Drug Shortages
Our Actions

Our Actions

To help strengthen our supply chain, McKesson has implemented a number of supply assurance strategies to help maintain a consistent flow of vital medications and healthcare products for providers, patients and pharmacy customers.

Learn More
Our Advocacy

Our Advocacy

We are eager to work with all stakeholders to address the drug shortage problem, and McKesson’s Public Affairs team advocates for public policy proposals that will prevent or mitigate shortages in the future.

Learn More
Industry Partnerships

Our Industry Partnerships

McKesson actively collaborates and holds leadership roles in key industry organizations, and supports nonprofit partners dedicated to solving the pharmaceutical supply challenges that disrupt access to essential medications in the U.S.

Learn More

top